aldosteronin

Aldosteronin is a fictional steroid hormone described in pharmacology literature as a mineralocorticoid. Designed to resemble aldosterone, it is used in teaching and modeling to study how mineralocorticoids regulate electrolyte balance and blood pressure. In simulations, aldosteronin is characterized by high affinity for the mineralocorticoid receptor (MR) and by selective activation of MR-dependent gene transcription.

Chemistry and mechanism: Aldosteronin shares the core steroid nucleus of endogenous corticosteroids with structural features that promote MR binding, including functional groups analogous to those in aldosterone. In preclinical assays, it shows strong MR selectivity and can upregulate transcription of epithelial sodium channels (ENaC) and Na+/K+-ATPase in renal principal cells, increasing sodium reabsorption and potassium excretion. The net effect in renal tissue is enhanced sodium and water retention, contributing to modest increases in extracellular fluid volume and blood pressure in model systems.

Pharmacokinetics and status: As a fictional compound, aldosteronin does not have approved pharmacokinetic data. In classroom and in silico studies, it is assumed to be orally active or injectable, with hepatic metabolism and renal or biliary excretion. Adverse effects projected in models include hypertension, edema, and hypokalemia, reflecting its MR-mediated actions. It is not approved for clinical use and is used primarily for educational and theoretical modeling.

See also: Aldosterone; Mineralocorticoid receptor.